TrialJournal of translational medicine2025

Overview of preclinical and phase II clinical studies on Pegmolesatide's long-term erythropoiesis stimulating effect via EPOR-mediated signal transduction.

Xiaoying Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.